Sperm Protein 17 is a Suitable Target for Adoptive T-cell–based Immunotherapy in Human Ovarian Cancer

Maurizio Chiriva‐Internati(Texas Tech University), W. Martin Kast(University of Southern California), Eldo E. Frezza(Texas Tech University), Everardo Cobos(Texas Tech University), Yuefei Yu(Texas Tech University), Marjorie Jenkins(United States Food and Drug Administration), Ronald C. Kennedy(Texas Tech University), Jon A. Weidanz(The University of Texas at Arlington)
Journal of Immunotherapy
September 19, 2008
Cited by 21


Related Papers